Evaluation of early biomarkers of muscle anabolic response to testosterone

Journal of Cachexia, Sarcopenia and Muscle

Volumn 2, Issue 1, 2011, Pages 45-56

  Chen, Fabian ^a   Lam, Raymond ^a   Shaywitz, David ^a,e   Hendrickson, Ronald C ^a   Opiteck, Gregory J ^a   Wishengrad, Dana ^a   Liaw, Andy ^a   Song, Qinghua ^a   Stewart, Adrian J ^b   Cummings, Corinne E ^c   Beals, Chan ^a   Yarasheski, Kevin E ^d   Reicin, Alise ^a   Ruddy, Marcella ^a   Hu, Xuguang ^a   Yates, Nathan A ^a   Menetski, Joseph ^a   Herman, Gary A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b MDS Pharma Services   (United Kingdom)

^c Merck Sharp & Dohme Limited   (United Kingdom)

^d WASHINGTON UNIVERSITY   (United States)

^e THERAVANCE INC   (United States)

Author keywords

Frailty; Mass spectrometry; Proteomics; RNA microarray profiling; Sarcopenia; Testosterone

Indexed keywords

BIOLOGICAL MARKER; MUSCLE PROTEIN; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; SODIUM CHLORIDE; TESTOSTERONE ENANTATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMMUNITY LIVING; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; GENE EXPRESSION PROFILING; GENETIC CODE; HUMAN; HUMAN TISSUE; LOW DRUG DOSE; MALE; MUSCLE METABOLISM; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; SKELETAL MUSCLE PROTEIN FRACTIONAL SYNTHESIS RATE;

EID: 80655145284     PISSN: 21905991     EISSN: 21906009     Source Type: Journal    
DOI: 10.1007/s13539-011-0021-y     Document Type: Article

References (54)

1. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998; 147: 755-63.
2. Von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle. 2010; 1: 129-33.
3. Lenk K, Schuler G, Adams V. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachexia Sarcopenia Muscle. 2010; 1: 9-21.
4. Tellado JM, Garcia-Sabrido JL, Hanley JA, Shizgal HM, Christou NV. Predicting mortality based on body composition analysis. Ann Surg. 1989; 209: 81-7.
5. Bhasin S, Woodhouse L, Casaburi R, et al. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab. 2001; 281: E1172-81.
6. Bhasin S, Woodhouse L, Casaburi R, et al. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab. 2005; 90: 678-88.
7. Ferrando AA, Sheffield-Moore M, Yeckel CW, et al. Testosterone administration to older men improves muscle function: molecular and physiological mechanisms. Am J Physiol Endocrinol Metab. 2002; 282: E601-7.
8. Prockop DJ, Kivirikko KI, Tuderman L, Guzman NA. The biosynthesis of collagen and its disorders (first of two parts). N Engl J Med. 1979; 301: 13-23.
9. Risteli J, Niemi S, Trivedi P, Maentausta O, Mowat AP, Risteli L. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem. 1988; 34: 715-8.
10. Biolo G, Fleming RY, Maggi SP, Wolfe RR. Transmembrane transport and intracellular kinetics of amino acids in human skeletal muscle. Am J Physiol. 1995; 268: E75-84.
11. Biolo G, Declan Fleming RY, Wolfe RR. Physiologic hyperinsulinemia stimulates protein synthesis and enhances transport of selected amino acids in human skeletal muscle. J Clin Invest. 1995; 95: 811-9.
12. Kirkman MA. Comparative determination of protein amino acids in plant materials by automated cation exchange and gas-liquid chromatography of the amino acid N-heptafluorobutyryl, n-propyl esters. J Chromatogr. 1974; 97: 175-91.
13. CD WRR. Isotope tracers in metabolic research: principles and practice of kinetic analysis. 2nd ed. Hoboken: Wiley-Liss; 2005.
14. Bateman RJ, Munsell LY, Chen X, Holtzman DM, Yarasheski KE. Stable isotope labeling tandem mass spectrometry (SILT) to quantify protein production and clearance rates. J Am Soc Mass Spectrom. 2007; 18: 997-1006.
15. Yarasheski KE, Smith SR, Powderly WG. Reducing plasma HIV RNA improves muscle amino acid metabolism. Am J Physiol Endocrinol Metab. 2005; 288: E278-84.
16. Yarasheski KE, Smith K, Rennie MJ, Bier DM. Measurement of muscle protein fractional synthetic rate by capillary gas chromatography/combustion isotope ratio mass spectrometry. Biol Mass Spectrom. 1992; 21: 486-90.
17. Hasten DL, Pak-Loduca J, Obert KA, Yarasheski KE. Resistance exercise acutely increases MHC and mixed muscle protein synthesis rates in 78-84 and 23-32 yr olds. Am J Physiol Endocrinol Metab. 2000; 278: E620-6.
18. Meng F, Wiener MC, Sachs JR, et al. Quantitative analysis of complex peptide mixtures using FTMS and differential mass spectrometry. J Am Soc Mass Spectrom. 2007; 18: 226-33.
19. Paweletz CP, Wiener MC, Bondarenko AY, et al. Application of an end-to-end biomarker discovery platform to identify target engagement markers in cerebrospinal fluid by high resolution differential mass spectrometry. J Proteome Res. 2010; 9: 1392-401.
20. Jonckheere AR. A distribution-free k-sample test against ordered alternatives. Biometrika. 1954; 41: 133-45.
21. Terpstra TJ. The asymptomatic normality and consistency of Kendall's test against trend, when ties are present in one ranking. Inigationes Mathmaticae. 1952; 14: 327-33.
22. Nair KS, Halliday D, Griggs RC. Leucine incorporation into mixed skeletal muscle protein in humans. Am J Physiol. 1988; 254: E208-13.
23. Volpi E, Mittendorfer B, Rasmussen BB, Wolfe RR. The response of muscle protein anabolism to combined hyperaminoacidemia and glucose-induced hyperinsulinemia is impaired in the elderly. J Clin Endocrinol Metab. 2000; 85: 4481-90.
24. Welle S, Thornton C, Jozefowicz R, Statt M. Myofibrillar protein synthesis in young and old men. Am J Physiol. 1993; 264: E693-8.
25. Rennie MJ, Edwards RH, Halliday D, Matthews DE, Wolman SL, Millward DJ. Muscle protein synthesis measured by stable isotope techniques in man: the effects of feeding and fasting. Clin Sci (Lond). 1982; 63: 519-23.
26. Watt PW, Lindsay Y, Scrimgeour CM, et al. Isolation of aminoacyl-tRNA and its labeling with stable-isotope tracers: use in studies of human tissue protein synthesis. Proc Natl Acad Sci USA. 1991; 88: 5892-6.
27. Ljungqvist OH, Persson M, Ford GC, Nair KS. Functional heterogeneity of leucine pools in human skeletal muscle. Am J Physiol. 1997; 273: E564-70.
28. Takala TE, Vuori J, Anttinen H, Vaananen K, Myllyla R. Prolonged exercise causes an increase in the activity of galactosylhydroxylysyl glucosyltransferase and in the concentration of type III procollagen aminopropeptide in human serum. Pflugers Arch. 1986; 407: 500-3.
29. Crameri RM, Langberg H, Teisner B, et al. Enhanced procollagen processing in skeletal muscle after a single bout of eccentric loading in humans. Matrix Biol. 2004; 23: 259-64.
30. Nelson AE, Meinhardt U, Hansen JL, et al. Pharmacodynamics of growth hormone abuse biomarkers and the influence of gender and testosterone: a randomized double-blind placebo-controlled study in young recreational athletes. J Clin Endocrinol Metab. 2008; 93: 2213-22.
31. Wallace JD, Cuneo RC, Lundberg PA, et al. Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males. J Clin Endocrinol Metab. 2000; 85: 124-33.
32. Garma T, Kobayashi C, Haddad F, Adams GR, Bodell PW, Baldwin KM. Similar acute molecular responses to equivalent volumes of isometric, lengthening, or shortening mode resistance exercise. J Appl Physiol. 2007; 102: 135-43.
33. Longobardi S, Keay N, Ehrnborg C, et al. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group. J Clin Endocrinol Metab. 2000; 85: 1505-12.
34. Bhasin S, He EJ, Kawakubo M, et al. N-terminal propeptide of type III procollagen as a biomarker of anabolic response to recombinant human GH and testosterone. J Clin Endocrinol Metab. 2009; 94: 4224-33.
35. Meduri GU, Tolley EA, Chinn A, Stentz F, Postlethwaite A. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Am J Respir Crit Care Med. 1998; 158: 1432-41.
36. Xie SB, Yao JL, Zheng RQ, Peng XM, Gao ZL. Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis. Hepatobiliary Pancreat Dis Int. 2003; 2: 69-72.
37. Poulsen SH, Host NB, Jensen SE, Egstrup K. Relationship between serum amino-terminal propeptide of type III procollagen and changes of left ventricular function after acute myocardial infarction. Circulation. 2000; 101: 1527-32.
38. Ferrando AA, Tipton KD, Doyle D, Phillips SM, Cortiella J, Wolfe RR. Testosterone injection stimulates net protein synthesis but not tissue amino acid transport. Am J Physiol. 1998; 275: E864-71.
39. Sheffield-Moore M, Paddon-Jones D, Casperson SL, et al. Androgen therapy induces muscle protein anabolism in older women. J Clin Endocrinol Metab. 2006; 91: 3844-9.
40. Ferrando AA, Sheffield-Moore M, Paddon-Jones D, Wolfe RR, Urban RJ. Differential anabolic effects of testosterone and amino acid feeding in older men. J Clin Endocrinol Metab. 2003; 88: 358-62.
41. 13C]Leucine enrichment in human muscle protein. Anal Biochem. 1996; 239: 77-85.
42. Giannoulis MG, Jackson N, Shojaee-Moradie F, et al. The effects of growth hormone and/or testosterone on whole body protein kinetics and skeletal muscle gene expression in healthy elderly men: a randomized controlled trial. J Clin Endocrinol Metab. 2008; 93: 3066-74.
43. Henderson GC, Dhatariya K, Ford GC, et al. Higher muscle protein synthesis in women than men across the lifespan, and failure of androgen administration to amend age-related decrements. FASEB J. 2009; 23: 631-41.
44. Yarasheski KE, Zachwieja JJ, Bier DM. Acute effects of resistance exercise on muscle protein synthesis rate in young and elderly men and women. Am J Physiol. 1993; 265: E210-4.
45. Yates NA, Deyanova EG, Geissler W, Wiener MC, Sachs JR, Wong KW, et al. Identification of peptidase substrates in human plasma by FTMS based differential mass spectrometry. Int J Mass Spectrom. 2007; 259: 174-83.
46. Sietsema KE, Meng F, Yates NA, et al. Potential biomarkers of muscle injury after eccentric exercise. Biomarkers. 2010; 15: 249-58.
47. MacNeill SA. Structure and function of the GINS complex, a key component of the eukaryotic replisome. Biochem J. 2010; 425: 489-500.
48. Bouche N, Scharlat A, Snedden W, Bouchez D, Fromm H. A novel family of calmodulin-binding transcription activators in multicellular organisms. J Biol Chem. 2002; 277: 21851-61.
49. Song K, Backs J, McAnally J, et al. The transcriptional coactivator CAMTA2 stimulates cardiac growth by opposing class II histone deacetylases. Cell. 2006; 125: 453-66.
50. Araki T, Milbrandt J. Ninjurin2, a novel homophilic adhesion molecule, is expressed in mature sensory and enteric neurons and promotes neurite outgrowth. J Neurosci. 2000; 20: 187-95.
51. Assmann EM, Alborghetti MR, Camargo ME, Kobarg J. FEZ1 dimerization and interaction with transcription regulatory proteins involves its coiled-coil region. J Biol Chem. 2006; 281: 9869-81.
52. 12 myocytes. J Biol Chem. 2008; 283: 10208-20.
53. McKoy G, Hou Y, Yang SY, et al. Expression of Ankrd2 in fast and slow muscles and its response to stretch are consistent with a role in slow muscle function. J Appl Physiol. 2005; 98: 2337-43. discussion 2320.
54. Von Haehling S, Morley JE, Coats AJS, Anker SD. Ethical guidelines for authorship and publishing in the journal of cachexia, sarcopenia and muscle. J Cachexia Sarcopenia Muscle. 2010; 1: 7-8.